When the Dollar Strengthens and FIIs Sell India — Here is Which Indian Sectors Win and Which Ones Bleed

Introduction

Every time the US Federal Reserve raises interest rates, a very predictable sequence plays out in Indian markets.

• The Dollar strengthens.
• The Rupee weakens.
• FIIs (Foreign Institutional Investors) start pulling money out of Indian equities.

Why do FIIs start selling? Because they are moving their funds out of India into US bonds. Now, in the US, they can earn a better risk-adjusted return as the bond yield has gone up.

When Indian markets fall, most retail investors watch their portfolios shrink without fully understanding why.

But it is also important to understand another thing about falling stock prices when FIIs sell in India.

• Not every sector falls equally.
• Some sectors in India actually benefit when the Dollar strengthens, and the Rupee weakens.
• Others get hit very hard.

Knowing this distinction is not just interesting information; it is genuinely useful for portfolio decisions.

In this post, I’ll talk about exactly this:

Which Indian sectors bleed during a strong-Dollar and FII-selling cycle? Which ones quietly benefit in this scenario?

1. First, Let Us Understand the Scale of FII Impact

Before we get into sectors, it is worth appreciating just how much FII money moves Indian markets.

FIIs hold somewhere between 17% to 20% of the total market capitalisation of NSE-listed companies. That is a significant chunk.

And when they decide to sell, they sell in size. When FIIs are selling, they do it in thousands of crores, causing almost a market crash.

In calendar year 2022:

The US Federal Reserve aggressively hiked rates, raising them from near zero to 4.5% within a single year. At that time, FIIs sold over Rs. 1.4 lakh crore of Indian equities.

That is roughly 170 billion US Dollars worth of selling in one year.

At that time, the Nifty 50 fell from around 18,350 in January 2022 to approximately 15,183 by June 2022. This was a fall of about 17% in six months.

In October 2024:

When Dollar strength re-emerged, FIIs sold close to Rs. 94,000 crore in Indian equities in a single month. It was one of the largest monthly outflows on record.

The Rupee, during this same period, slid from around 83.5 to nearly 84.4 against the Dollar.

These are not small numbers.

And within these broad market falls, some sectors fell much harder than others.

2. Sectors That Bleed

These are the sector casualties when the Dollar becomes strong.

2.1. Oil Marketing Companies (OMCs)

This is the most direct casualty of a strong Dollar.

• Companies like HPCL, BPCL, and Indian Oil import crude oil in US Dollars and sell refined products domestically in Rupees.
• When the Rupee weakens, their import costs rise automatically.
• But they cannot always pass on the full increase to consumers immediately, especially when the government controls fuel prices for political reasons.

The margin compression for OMCs during Dollar-strength cycles can be severe.

In FY2022-23:

• HPCL reported a net loss of over Rs. 6,900 crore mainly because of exactly this dynamic. Rising crude prices, combined with a weakening Rupee, drastically reduced their refining margins.
• BPCL’s profitability fell sharply in the same period for similar reasons.

As a general rule, when the Dollar is strengthening, OMCs are not the stocks where you want to be.

2.2. Aviation

Aviation is another sector that suffers directly.

Airline stocks like IndiGo, Spice Jet, etc face a double hit. Aviation

• Turbine Fuel is priced in Dollars.
• Aircraft lease payments are in Dollars.
• Maintenance contracts are in Dollars.

A large portion of their costs is dollar-denominated, while almost all their revenues are in Rupees.

IndiGo, despite being one of the most efficiently run airlines in Asia, has repeatedly flagged currency related issues in its quarterly earnings calls. This happens during periods of Rupee weakness.

It is said that every one-Rupee depreciation against the Dollar adds roughly Rs. 70 to 100 crore to IndiGo’s annual costs.

2.3. Companies With Dollar-Denominated Debt

Some Indian infrastructure and real estate companies have borrowed in Dollars.

Why do they borrow from abroad? Often, because international rates were lower.

But when the Rupee weakens, the Rupee value of that debt increases automatically. This will happen even if they have not borrowed a single additional Rupee.

This can quietly destroy balance sheets. A few examples of the past are as follows:

1. Suzlon Energy: The company had taken debt on large foreign currency convertible bonds to fund its global acquisitions, including the purchase of REpower in Germany. When the Rupee weakened and the business underperformed, Suzlon defaulted on its FCCBs in 2012. This was widely covered by The Economic Times at the time. Suzlon spent years restructuring its debt and selling assets to survive.
2. Reliance Communications (RCom): Accumulated significant dollar-denominated debt. As the Rupee weakened and the telecom business deteriorated under competitive pressure from Jio, the company’s ability to service that foreign currency debt collapsed. RCom eventually went into insolvency proceedings under the NCLT (2017-2019) – read more here.
3. Jaiprakash Associates: Carried very large foreign currency borrowings taken on to fund infrastructure and real estate projects. When project cash flows did not materialise as expected, and the Rupee weakened, the debt burden became unmanageable (read more here).
4. GMR Infrastructure: It owns and operates airports and energy assets. They had significant forex-denominated debt on their books, which was particularly related to their overseas airport projects. During 2012 to 2014, when the Rupee fell sharply against the Dollar (from around 50 to nearly 68) GMR faced considerable balance sheet stress. The company was reported to be in discussions with lenders for debt restructuring during this period (read more).
5. IL&FS: It had a complex mix of rupee and foreign currency borrowings across its many subsidiaries. When the group collapsed in 2018, it emerged that several IL&FS entities had foreign currency exposure that was inadequately hedged (read about it here).

3. Sectors That Win

3.1. IT Exporters

This is the most well-known beneficiary, and for good reason.

Companies like the following:

• TCS,
• Infosys,
• Wipro,
• HCL Technologies, and
• Tech Mahindra

They earn a significant portion of their revenue in US Dollars.

The majority of their costs, primarily employee salaries, are in Rupees.

Hence, when the Rupee weakens by 1%, the Rupee-reported revenue of these companies goes up by roughly 1%. For this growth, they had to do nothing additional.

This is called a currency tailwind.

During the 2022 Dollar-strengthening cycle, when the Rupee depreciated from around 74 to 83 against the Dollar (a 12% weakening), large-cap IT companies saw meaningful margin improvements from the currency alone.

Infosys and TCS both reported stronger-than-expected Rupee revenues in that period, partly because of the Indian Rupee becoming weaker.

For context, TCS alone earns roughly 55% of its revenue from North America. A sustained Dollar-strength cycle is genuinely good for their reported numbers.

3.2. Pharma Exporters

The Indian pharmaceutical industry exports heavily to the United States.

Companies like the following:

• Sun Pharma,
• Dr. Reddy’s Laboratories,
• Cipla, and
• Aurobindo Pharma

They earn a substantial share of their revenues in Dollars.

Dr. Reddy’s, for instance, derives roughly 45 to 50% of its total revenues from North America.

Sun Pharma’s US business is similarly significant.

A weaker Rupee directly improves the Rupee realisation from every Dollar they earn.

These companies tend to hold up relatively better during FII selling cycles compared to domestic-focused sectors.

3.3. Specialty Chemicals and Textile Exporters

This is also an important group.

Specialty chemicals companies like the following:

• PI Industries,
• SRF, and
• Navin Fluorine has significant export revenues.

Similarly, textile exporters also benefit from Rupee depreciation because their products become cheaper and more competitive in global markets when priced in Dollars.

Here are a few Indian textile companies that benefit in a weak rupee scenario:

• Page Industries: It is India’s largest innerwear manufacturer (Jockey licensee), with significant export revenues, and directly benefits from Rupee depreciation on its export realisations.
• Welspun India — It exports towels, bed linen, and flooring products primarily to the US and UK. A weaker Rupee directly boosts their Dollar earnings when converted.
• Trident Limited — It is also a major exporter of terry towels and yarn to the US and European markets. It is also consistently among the top beneficiaries when the Rupee weakens.
• KPR Mill — It is an integrated textile manufacturer with strong garment export revenues from Europe. Currency tailwind is a meaningful contributor to their margins.
• Arvind Limited — It is a diversified textile company with denim and fabric exports to global markets. Has historically reported improved export realisations during Rupee-weakness cycles.
• Himatsingka Seide — It is a textile exporter focused heavily on the US market. They export bed linen and soft furnishing products. High dollar revenue exposure makes it a direct beneficiary.
• Indo Count Industries — This is entirely an export-focused company. They primarily sell bed sheets and home textiles in the US. It is one of the purest plays on Rupee depreciation among listed textile companies.

Note: Indo Count and Welspun are generally considered the most direct beneficiaries among these, given their near-complete dependence on export revenues.

These two sectors (Speciality Chemicals and Textile) do not move as dramatically as IT, but benefit from dollar strengthening for sure.

4. Portfolio Positioning

I do not think anyone should make dramatic portfolio shifts every time the Dollar moves.

That kind of trading is exhausting and usually leads to poor outcomes.

But what I do think is sensible, especially for investors who are building a medium-term portfolio, is to be aware of your sector exposures during different macro environments.

• When US bond yields are rising, and the Dollar is strengthening, being overweight OMCs or aviation without understanding the currency risk is not good portfolio management.
• Equally, during such cycles, IT and pharma exporters tend to provide a natural hedge within your equity portfolio (they fall less). They can also hold steady when the broader market is declining due to FII outflows.

5. A Watchlist of Mid and Small Cap Exporters With Strong Fundamentals

The stocks discussed above are well-known names.

Most of your readers already hold or track them.

But within the same Dollar-benefit theme, some genuinely strong mid and small-cap companies deserve a closer look.

They are fundamentally sound businesses that structurally benefit every time the Rupee weakens against the Dollar.

SL	Name of Stock	Approx. Price (Rs.)	Approx. Market Cap (Rs. Cr)	Remark
1	Indo Count Industries	245	4,818	Near-pure play US home textile exporter. Over 90% revenues from exports.
2	Caplin Point Laboratories	1685	12,823	Niche pharma exporter focused on Latin America and Francophone Africa — markets with less pricing pressure than the US generics market. Debt-free. Consistently high ROE.
3	Garware Technical Fibres	610	6,078	Exports high-value technical textiles to over 70 countries. Dominant global market position. Strong margins. Debt-free.
4	KPIT Technologies	710	19,460	Focused purely on automotive and mobility software. Significant revenues in Euros and Dollars. Clean balance sheet and strong earnings growth trajectory.
5	Cyient Limited	900	9,955	Engineering and technology services exporter (aerospace, defence, utilities). High-Dollar revenue mix. Less tracked than tier-1 IT but fundamentally very sound.
6	Tarsons Products	202	1,069	Manufactures laboratory plasticware. Exports to research institutions and pharma companies globally. Import substitution story domestically. Has an asset-light model.
7	Mastek Limited	1560	4,869	Mid-cap IT services company with a strong presence in UK government digital projects and US healthcare. High revenue visibility and a consistent dividend payer.

Disclaimer: This is not investment advice. Please do your own due diligence before making any investment decision.

If you found it useful, I would genuinely love to hear your thoughts in the comments below.

Have a happy investing.